This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA369110; GEO: GSE94237 |
| Type | Umbrella project |
| Publications | Mattsson J et al., "Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata.", Skin Health Dis, 2023 Jun;3(3):e209 |
| Submission | Registration date: 27-Jan-2017
Translational Biology, AstraZeneca, IMED RIA |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 44 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 44 |
| GEO DataSets | 3 |
JAK inhibition in human CD8+ T-cells and C3H/HeJ Mice with Alopecia Areata In Vivo encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Transcriptome or Gene expression | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA369115 | Homo sapiens | Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata (Translational Biology, AstraZeneca,...) | | PRJNA369114 | Mus musculus | Effect of systemic exposure of JAK1 Inhibition (AZ13748709) in C3H/HeJ Mice with Alopecia Areata In Vivo (Translational Biology, AstraZeneca,...) |
|